News Bastide Le Confort Médical BOERSE MUENCHEN

Equities

1DJ

FR0000035370

Real-time BOERSE MUENCHEN Other stock markets 10:13:08 28/06/2024 BST			5-day change	1st Jan Change
18.12 ^EUR	0.00%		-5.08%	-29.96%

05-15	BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction
05-15	Bastide: 8.2% increase in quarterly sales	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction	05-15
Bastide: 8.2% increase in quarterly sales	05-15	CF
Bastide Le Confort Médical : Organic growth accelerated in third quarter 2023-2024 up 7.5% and sale of Homecare business in Switzerland in progress	05-15	AT
2024.05.15 Organic growth accelerated in third quarter 2023 2024: up 7.5% Sale of Homecare business in Switzerland in progress 2023 2024 targets adjusted from scope effect confirmed	05-15	PU
BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%)	04-09
Bastide: new contract with the British NHS	04-09	CF
Bastide Le Confort Médical : Respiratory care therapy: Bastide wins new United Kingdom region - EUR 10 million/year contract for a minimum of seven years	04-08	AT
BASTIDE LE CONFORT MEDICAL : The prioritised debt reduction awaits further visible progress	03-21
Bastide Le Confort Médical : 2023-2024 half-yearly results : Organic growth up 5.7%, EBITDA up 7.5%, Increase in recurring operating profit despite the inflationary context and margin of 8.3%. 2023-2024 outlook confirmed	03-20	AT
Bastide Le Confort Médical SA Reports Earnings Results for the Half Year Ended December 31, 2023	03-20	CI
BASTIDE LE CONFORT MEDICAL : Reiterated guidance and further progress on the in debt profile	02-15
Bastide: half-year sales up 5.7% organically	02-15	CF
Bastide Le Confort Médical : Organic growth accelerated to 6.1% in second-quarter 2023-2024 and confirmation of 2023-2024 adjusted targets	02-15	AT
Bastide Le Confort Offloads Majority Owned Medical Devices Seller Distrimed	12-05	MT
Bastide: sells its Distrimed subsidiary to the Hygie31 group	12-04	CF
Bastide Le Confort Médical : Strategic sale of e-commerce subsidiary Distrimed	12-04	AT
Hygie31 acquired 70% stake in Distrimed SAS from Bastide Le Confort Médical SA.	12-03	CI
BASTIDE LE CONFORT MEDICAL : Reconfirmed outlook and early progress in debt profile improvement	11-19
Bastide: 7% sales growth in Q1	11-17	CF
Bastide Le Confort Médical : Dynamic 7% growth in first-quarter 2023-2024 / 2023-2024 targets confirmed	11-16	AT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction

May 15, 2024 at 07:40 pm